SCHEMBL27755298

SCHEMBL27755298

CN(C)c1ccc(C=C2CNc3ccccc32)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 8/20 0.52
▸ APP P05067 5/20 0.52
▸ SNCA P37840 5/20 0.52
▸ MEN1 O00255 4/20 0.52
▸ KMT2A Q03164 4/20 0.52
▸ ALDH1A1 P00352 3/20 0.52
▸ MAPK1 P28482 3/20 0.52
▸ MAOB P27338 3/20 0.52
▸ LMNA P02545 3/20 0.52
▸ NPC1 O15118 3/20 0.52
▸ RAB9A P51151 3/20 0.52
▸ SMN1; SMN2 Q16637 3/20 0.52
▸ PDGFRB P09619 2/20 0.52
▸ TDP1 Q9NUW8 2/20 0.52
▸ CYP1A2 P05177 2/20 0.52
▸ HPGD P15428 2/20 0.52
▸ MAOA P21397 2/20 0.52
▸ GMNN O75496 1/20 0.52
▸ MTOR P42345 1/20 0.52
▸ BLM P54132 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28129799 0.82 MAOB (0.43) MAPTMEN1KMT2AALDH1A1MAPK1
SCHEMBL16427344 0.80 KDR (0.49) MAOBMAOAPIM1PIM2
SCHEMBL16427343 0.80 KDR (0.49) MAOBMAOAPIM1PIM2
SCHEMBL16426717 0.80 MAOB (0.48) MAOBMAOAPIM1PIM2
SCHEMBL16426716 0.80 MAOB (0.48) MAOBMAOAPIM1PIM2
SCHEMBL16426758 0.77 RAB9A (0.55) MAPTMEN1KMT2AALDH1A1MAPK1
SCHEMBL16426757 0.77 RAB9A (0.55) MAPTMEN1KMT2AALDH1A1MAPK1
SCHEMBL16426515 0.76 ELANE (0.43) MAPTMEN1KMT2AALDH1A1MAPK1
SCHEMBL16426516 0.76 ELANE (0.43) MAPTMEN1KMT2AALDH1A1MAPK1
SCHEMBL15291319 0.71 JAK2 (0.39) MEN1KMT2AALDH1A1MAPK1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101495147-B Pharmaceutical combinations. NOVARTIS AG 2012-01-25 — — CN disclosed
CN-101495147-A Pharmaceutical combinations. NOVARTIS AG (CH) 2009-07-29 — — CN disclosed
Send feedback